LSD1 inhibition downregulates ASCL1 and neuroendocrine differentiation in some SCLC cell lines and ASCL1 downregulation correlates with LSD1 inhibitor sensitivity in SCLC cell lines and PDX models7. The gene discussed is KDM1A; the disease is small cell lung carcinoma.